EL CAJON, Calif.–( SERVICE CABLE)– #Biofilm– PURE Bioscience, Inc. (OTCQB: PURE) (” PURE,” the “Business” or “we”), maker of the copyrighted safe silver dihydrogen citrate (SDC) antimicrobial, today reported economic outcomes for the finished July 31, 2024. Recap of Outcomes– Year-End Procedures Internet item sales were $1,955,000 and $1,871,000 for the finished July 31, 2024 and 2023, specifically. The boost of $84,000 was attributable to boosted sales throughout our circulation ne
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/pure-bioscience-reports-fiscal-2024-financial-results/
